Achaogen Financials

Achaogen Stock Summary

Achaogen competes with Ecolab, JJill, Steven Madden, Braskem SA, and Vince Holding. Achaogen, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibacterial agents for multi-drug resistant gram-negative infections in the United States. On April 15, 2019, Achaogen, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Achaogen operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 42 people.

Achaogen Key Financial Ratios

Generally speaking, Achaogen's financial ratios allow both analysts and investors to convert raw data from Achaogen's financial statements into concise, actionable information that can be used to evaluate the performance of Achaogen over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Achaogen reports annually and quarterly.

Achaogen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Achaogen's current stock value. Our valuation model uses many indicators to compare Achaogen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Achaogen competition to find correlations between indicators driving Achaogen's intrinsic value. More Info.Achaogen is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Achaogen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Achaogen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Achaogen's earnings, one of the primary drivers of an investment's value.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Achaogen information on this page should be used as a complementary analysis to other Achaogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

If you are still planning to invest in Achaogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achaogen's history and understand the potential risks before investing.